AI assistant
Indoco Remedies Ltd. — Call Transcript 2022
Nov 7, 2022
62453_rns_2022-11-07_5004b2d7-e9bc-4a56-8402-fc77e0ef114a.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [187 x 66] intentionally omitted <==
November 7, 2022
| To The Manager Listing Department National Stock Exchange of India Limited ‘Exchange Plaza’, C - 1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai 400051. Scrip Code: INDOCO |
To BSE Limited Corporate Relationship Department 1stFloor, New Trading Ring, Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400001 Scrip Code : 532612 |
||
|---|---|---|---|
Dear Sirs,
Sub: Schedule of Con Call Meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find for your information and record the scheduled Con Call meeting planned for Friday, November 11, 2022.
Thanking you,
Yours faithfully,
for Indoco Remedies Limited
JAYSHANKAR Digitally signed by JAYSHANKAR MENON MENON Date: 2022.11.07 11:52:20 +05'30' Jayshankar Menon Company Secretary &AVP (Legal)
==> picture [557 x 134] intentionally omitted <==
==> picture [106 x 25] intentionally omitted <==
==> picture [85 x 10] intentionally omitted <==
----- Start of picture text -----
CORPORATE ACCESS
----- End of picture text -----
==> picture [130 x 43] intentionally omitted <==
JM Financial Institutional Securities invites you to the
2QFY 2022-23 earnings conference call with
Indoco Remedies Limited
on Friday, 11 November 2022
11:00 AM IST | 00:30 AM USA EDT | 05:30 AM UK TIME | 01:30 PM HK/SINGAPORE TIME
Company Participants
Ms. Aditi Panandikar
Managing Director
Mr. Sundeep V Bambolkar
Jt. Managing Director
Mr. Pramod Ghorpade
Chief Financial Officer
Universal Dialin:
+91-22-6280 1366 / +91-22-7115 8267
Toll Free Number – International UK:
USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448
Please dial-in 10 minutes prior to the conference schedule to ensure that you are connected in time
Diamond Pass Link:
==> picture [188 x 39] intentionally omitted <==
For further information, please contact
Ms. Cyndrella Carvalho | +91-22-6630 3056 | [email protected] Mr. Jainil Shah | +91-22-6630 1877 | [email protected] Ms. Ninie Singh | +91-22-6630 3481 | [email protected] Ms. Lorraine Gomes | +91-22-6630 3076 | [email protected]
JM Financial Institutional Securities Limited
Corporate Identity Number: U67100MH2017PLC296081
Member of BSE Ltd., National Stock Exchange of India Ltd. and Metropolitan Stock Exchange of India Ltd. SEBI Registration Nos.: – Stock Broker - INZ000163434, Research Analyst – INH000000610 Registered Office: 7th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India. Board: +91-22-6630 3030 | Fax: +91-22-6630 3488 | Email: [email protected] | www.jmfl.com Compliance Officer: Mr. Sunny Shah | Tel: +91-22-6630 3383 | Email: [email protected]
Safe harbor:
The proposed management discussion and comments thereof may include forward-looking statements. Forward-looking statements are statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. All forward looking statements are subject to risks, uncertainties and assumptions that could cause actual results of operations and financial conditions to differ materially from those contemplated by the relevant statement. All Conference Call Participants should not place undue reliance on these forward-looking statements
- means the place/city is observing daylight saving time (DST) at time shown